As of January 22, 2025, Gossamer Bio (GOSS) has a market cap of $0.20 billion USD. According to our data, Gossamer Bio is ranked No.7086 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.20 B |
-0.33%
|
Dec 31, 2024 | $0.21 B |
-0.88%
|
Dec 29, 2023 | $0.21 B |
-57.93%
|
Dec 30, 2022 | $0.49 B |
-80.81%
|
Dec 31, 2021 | $2.56 B |
16.96%
|
Dec 31, 2020 | $2.19 B |
-38.13%
|
Dec 31, 2019 | $3.54 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Market Cap | = | GOSS Stock Price | * | GOSS Shares Outstanding |
= | $0.90 | * | 0.23 B | |
= | $0.20 B |